Service area · Wholesale distribution of medicinal products
Last updated: 27 August 2026
Verify, approve and monitor authorised medicine suppliers, customers, delivery addresses and critical service providers.
Design partner qualification →GDP supply chain · due diligence · monitoring
Verify, approve and monitor authorised medicine suppliers, customers, delivery addresses and critical service providers.
A controlled supply chain needs more than a certificate on file. We connect register checks, scope verification, risk assessment, quality agreements and blocking rules.
tiger.PHARMA Kompetenz
Manufacturers, importers and wholesalers are checked against product, activity, location and supply route.
Recipient eligibility must match the product, activity and actual delivery point.
Register results are interpreted for scope, status, site and date; one document alone is not sufficient.
Criticality and performance determine audit frequency, agreements and review cycles.
FAQ
Verify identity, site, activity, authorisation and GDP status using reliable registers and evidence, then document risk assessment, approval and periodic monitoring.
The wholesaler must verify that the recipient is entitled to receive the relevant medicines before supply. The depth and review cycle are risk-based.
No. Its issuer, site, scope and status must be assessed together with authorisation and supply-chain information.